DiaMedica Therapeutics Balance Sheet (2017-2026)

Reported Financials

DiaMedica Therapeutics Quarterly Balance Sheet

Periods 35 quarters

Latest Jun 2026

DiaMedica Therapeutics reported total assets of $45.00M and total liabilities of $6.66M for the quarter ended Jun 2026, up 43.0% year over year. This balance sheet covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Accumulated Depreciation	0.06M	0.07M	0.06M	0.07M	0.07M	0.08M	0.08M	0.09M	0.10M	0.10M	0.11M	0.10M	0.10M	0.11M	0.12M	0.13M	0.14M	0.15M	0.16M	0.16M
Receivables - AccuredAcc. Int. Receivables	0.10M	0.13M	0.17M	0.09M	0.07M	0.08M	0.06M	0.19M	0.31M	0.30M	0.39M	0.39M	0.29M	0.23M	0.23M	0.14M	0.23M	0.25M	0.28M	0.24M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	16.22M	4.71M	3.03M	3.06M	2.77M	4.73M	2.15M	5.84M	2.23M	4.54M	2.10M	14.07M	4.13M	3.02M	2.59M	4.11M	3.33M	15.65M	4.87M	5.13M
Receivables - NetNet Receivables	0.10M	0.13M	0.17M	0.09M	0.07M	0.08M	0.06M	0.19M	0.31M	0.37M	0.40M	0.39M	0.29M	0.24M	0.25M	0.16M	0.26M	0.26M	0.30M	0.24M
Receivables - OtherOther Receivables	0.10M	0.13M	0.17M			0.08M	0.06M	0.19M	0.31M	0.30M	0.39M	0.39M	0.29M	0.00M	0.23M	0.14M	0.23M	0.25M	0.28M	0.24M
Receivables	0.21M	0.26M	0.33M	0.09M	0.07M	0.16M	0.11M	0.37M	0.62M	0.67M	0.79M	0.78M	0.58M	0.24M	0.48M	0.30M	0.49M	0.51M	0.59M	0.48M
Inventory		0.11M				0.04M	0.09M	0.06M	0.71M	0.32M
Prepaid Assets	0.34M	0.20M	0.79M	0.53M	0.32M	0.25M	0.96M	0.68M	1.11M	0.41M	0.57M	0.57M	0.28M	0.23M	0.65M	0.68M	0.45M	0.48M	0.73M	0.57M
Current Assets	48.54M	45.44M	42.11M	39.17M	36.49M	33.84M	29.67M	41.23M	47.89M	53.67M	47.48M	55.01M	50.77M	44.61M	37.42M	31.08M	56.22M	60.63M	52.36M	44.31M
Non-Current Assets
Property, Plant & Equipment (Net)	0.07M	0.07M	0.07M	0.07M	0.11M	0.14M	0.14M	0.13M	0.14M	0.13M	0.13M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.14M	0.14M	0.13M
Long-Term Investments								20.30M	9.75M						1.00M
Other Non-Current Assets											1.31M	1.31M	1.31M	1.31M			0.46M	0.40M	0.40M	0.40M
Non-Current Assets	0.13M	0.11M	0.10M	0.09M	0.55M	0.56M	0.54M	20.82M	10.25M	0.48M	1.78M	1.78M	1.76M	1.74M	1.41M	0.39M	0.82M	0.74M	0.72M	0.69M
Assets	48.66M	45.55M	42.21M	39.26M	37.04M	34.40M	30.22M	62.05M	58.14M	54.16M	49.26M	56.79M	52.52M	46.34M	38.83M	31.47M	57.05M	61.37M	53.08M	45.00M
Liabilities
Current Liabilities
Accounts Payables	0.70M	0.51M	0.43M	0.62M	0.86M	0.73M	1.78M	0.86M	0.86M	0.93M	0.72M	0.76M	1.17M	0.94M	1.51M	1.26M	1.92M	1.48M	3.29M	2.81M
Notes Payables
Payables	0.70M	0.51M	0.43M	0.62M	0.86M	0.73M	1.78M	0.86M	0.86M	0.93M	0.72M	0.76M	1.17M	0.94M	1.51M	1.26M	1.92M	1.48M	3.29M	2.81M
Accumulated Expenses	0.86M	0.97M	0.97M	0.89M	0.64M	1.36M	0.96M	1.01M	1.23M	1.78M	1.81M	2.23M	3.02M	4.35M	3.05M	2.75M	3.24M	3.54M	2.34M	3.67M
Current Leases	0.06M	0.04M	0.03M	0.01M	0.03M	0.06M	0.07M	0.08M	0.08M	0.08M	0.08M	0.09M	0.09M	0.09M	0.09M	0.10M	0.10M	0.10M	0.10M	0.11M
Total Current Liabilities	1.62M	1.52M	1.43M	1.54M	1.54M	2.17M	2.81M	1.95M	2.17M	2.79M	2.62M	3.09M	4.30M	5.39M	4.67M	4.12M	5.27M	5.13M	5.75M	6.59M
Non-Current Liabilities
Capital Leases	0.00M		0.01M	0.01M	0.01M	0.00M	0.38M	0.36M	0.00M	0.00M		0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.00M
Operating Leases	0.06M	0.00M	0.03M	0.01M	0.46M	0.40M	0.45M	0.43M	0.41M	0.32M	0.38M	0.36M	0.34M	0.23M	0.29M	0.27M	0.25M	0.12M	0.20M	0.18M
Total Non-Current Liabilities	0.00M	0.00M	0.01M	0.01M	0.42M	0.40M	0.38M	0.36M	0.34M	0.32M	0.29M	0.29M	0.26M	0.24M	0.21M	0.18M	0.16M	0.13M	0.10M	0.07M
Total Liabilities	1.63M	1.53M	1.44M	1.54M	1.96M	2.57M	3.19M	2.31M	2.51M	3.10M	2.91M	3.38M	4.56M	5.63M	4.88M	4.30M	5.42M	5.26M	5.84M	6.66M
Shareholder's Equity
Total Debt
Common Equity	47.04M	44.02M	40.77M	37.72M	35.08M	31.83M	27.02M	59.74M	55.63M	51.06M	46.35M	53.41M	47.96M	40.72M	33.95M	27.17M	51.62M	56.11M	47.23M	38.34M
Liabilities and Shareholders Equity	48.66M	45.55M	42.21M	39.26M	37.04M	34.40M	30.22M	62.05M	58.14M	54.16M	49.26M	56.79M	52.52M	46.34M	38.83M	31.47M	57.05M	61.37M	53.08M	45.00M
Retained Earnings	126.30M	126.58M	126.88M	127.25M	127.67M	128.08M	128.50M	165.73M	166.15M	166.61M	167.10M	179.29M	179.99M	180.70M	181.66M	182.59M	215.60M	228.83M	230.07M	231.32M

DiaMedica Therapeutics DMAC Balance Sheet (2017-2026)

DiaMedica Therapeutics Quarterly Balance Sheet

Create an account

Sign In

Reset Password